Paul Quinlan | General Counsel |
Sujal Shah | Chief Executive Officer |
Chuck McWherter | Chief Scientific Officer and President, R&D |
Dennis Kim | Chief Medical Officer |
Lewis Stuart | Chief Commercial Officer |
Dan Menold | Vice President, Finance |
Steven Seedhouse | Raymond James |
Kristen Kluska | Cantor Fitzgerald |
Patrick Dolezal | LifeSci Capital |
Ed Arce | H.C. Wainwright & Co |
Mayank Mamtani | B. Riley |
Jay Olson | Oppenheimer |
Sean Kim | Jones Trading |
Good day, ladies and gentlemen and welcome to CymaBay’s Third Quarter 2022 Financial Results and Business Update Conference Call. [Operator Instructions] Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company’s request. It is also being webcast live on the Investors section at the CymaBay website at www.cymabay.com.
I would now like to turn the conference over to Mr.